Clinical Trial: Prospective Multiethnic Validation of the Behcet's Syndrome Overall Damage Index (BODI)

U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073261) titled 'Prospective Multiethnic Validation of the Behcet's Syndrome Overall Damage Index (BODI)' on June 27.

Brief Summary: PROBE is an observational multicenter cohort study, consisting of a cross-sectional and a 5-years prospective phase, designed to target the major study objectives, such as testing the comprehensiveness of the Behcet's syndrome Overall Damage Index (BODI) in a wide and ethnically heterogeneous cohort of Behcet's syndrome patients, and investigating how damage assessed by the BODI correlates with other major long-term disease outcomes (5-years mortality and hospitalization rates).

Study Start Date: July 23, 2021

Study ...